Pay in 4 interest-free payments of $22.50 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
PubMed PMID: 22388233
Use of [3H]fluorowillardiine to study properties of AMPA receptor allosteric modulators
5-3(6)1-2-4(7)8/h2-3
3-benzoxazol-2-one
Reversal of tubulin-VDAC interaction by erastin antagonizes Warburg metabolism and restores oxidative mitochondrial metabolism
Oclacitinib - CAS# 1208319-26-9 Catalog No.:M9848-2 PubMed PMID: 22388233Oclacitinib, also known as PF03394197, is a novel Janus kinase inhibitor with activity against cytokines involved in allergy. Oclacitinib inhibited JAK family members by 50% at concentrations (IC50 's) ranging from 10 to 99 nM and did not inhibit a panel of 38 non JAK kinases (IC50 's > 1000 nm). Oclacitinib was most potent at inhibiting JAK1 (IC50 = 10 nm). Oclacitinib also inhibited the function of JAK1 dependent cytokines involved in allergy and